October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Toni Choueiri: Extremely well-deserved honor for Eli Van Allen on his Chair
Oct 9, 2024, 14:32

Toni Choueiri: Extremely well-deserved honor for Eli Van Allen on his Chair

Toni Choueiri shared a post about Eli Van Allen. Read his post on X below:

“Massive congratulations and extremely well-deserved honor for our own Dana-Farber Cancer Institute’s Eli Van Allen on his Chair!

Eli leads our large Dana-Farber Division of Population Sciences and is part of the Dana-Farber Lank Center for Genitourinary Oncology as a GU Oncologist!”

Toni Choueiri: Extremely well-deserved honor for Eli Van Allen on his Chair

More posts featuring Toni Choueiri.

Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School.

As a medical oncologist, clinical trialist, and translational researcher, he specializes in treating genitourinary cancers (prostate, bladder, testis, and kidney cancer), with a focus on kidney cancer.

Eliezer (Eli) Van Allen is an Associate Professor of Medicine at Harvard Medical School and Chief of the Division of Population Sciences at the Dana-Farber Cancer Institute. He is also an Institute Member at the Broad Institute and a Member Researcher at The Parker Institute for Cancer Immunotherapy.

As a medical oncologist and computational biologist, he develops algorithms to analyze high-dimensional data from cancer patients to address key challenges in the field.